SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001739410-24-000040
Filing Date
2024-04-10
Accepted
2024-04-10 16:10:34
Documents
15
Period of Report
2024-04-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlyb-20240409.htm   iXBRL 8-K 35066
2 EX-99.1 exhibit991.htm EX-99.1 17200
6 img96626370_0.jpg GRAPHIC 8945
  Complete submission text file 0001739410-24-000040.txt   203448

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20240409.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20240409_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20240409_pre.xml EX-101.PRE 13575
18 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20240409_htm.xml XML 2917
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 24835880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)